Pfizer Inc. (NEO: PFE)

Market Cap	216.54B
Revenue (ttm)	80.12B
Net Income (ttm)	5.74B
Shares Out	n/a
EPS (ttm)	1.00
PE Ratio	37.74
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	21,331
Average Volume	51,162
Open	12.44
Previous Close	12.20
Day's Range	12.29 - 12.44
52-Week Range	11.40 - 14.73
Beta	0.62
RSI	50.95
Earnings Date	Feb 4, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women’s health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and po...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1849
• Employees: 88,000
• Stock Exchange: Cboe Canada
• Ticker Symbol: PFE

Financial Performance

In 2023, Pfizer's revenue was $58.50 billion, a decrease of -41.70% compared to the previous year's $100.33 billion. Earnings were $2.12 billion, a decrease of -93.25%.

Financial numbers in USD